Pharmacist · Epidemiologist · Public Health Researcher

Yusuff Adebayo Adebisi

Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.

Yusuff Adebayo Adebisi discussing research findings with a collaborator

About

Advancing health equity through evidence

Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.

His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.

Read full bio →
Yusuff Adebayo Adebisi — Epidemiologist and Public Health Researcher

Research Domains

Antimicrobial Resistance Tobacco Harm Reduction Smoking Cessation Infectious Disease Epidemiology Pandemic Preparedness Disability & Health

Explore

Explore my work

Research, career, funding and recognition.

Blog

Latest from the Blog

Thoughts on public health, equity, global health policy, and more.

A hand holding a smartphone showing an AI Quit Smoking Coach app beside a broken cigarette on a table, with the title Can AI Help You Quit Smoking? What 14 Randomised Trials Found
Featured

21 November 2026

Can AI Help You Quit Smoking? What 14 Randomised Trials Found

A systematic review and meta-analysis of 14 randomised controlled trials found that results tended to favour AI-enabled quit-smoking interventions but were not statistically conclusive — and no trial evaluated a ChatGPT-style generative AI assistant.

Read article →

21 November 2026

Smoking and Antibiotic Resistance: What Our Review of 43 Studies Found

A systematic review and meta-analysis of 43 observational studies with more than 35,000 participants found that people with a smoking history had 66% higher odds of antibiotic-resistant infection — with the evidence concentrated in drug-resistant tuberculosis.

Read article →

21 November 2026

Smoking, Vaping and Arthritis Risk: What a UK Study of 18,802 Adults Found

A longitudinal study of 18,802 UK adults in Understanding Society found a 43% higher adjusted risk of newly diagnosed arthritis among exclusive cigarette smokers and a 79% higher risk among dual users — but no clear association among exclusive e-cigarette users.

Read article →

23 October 2026

Complete Switching to E-Cigarettes Is Linked to Lower Toxicant Exposure

A systematic review and meta-analysis of 60 human studies found that every pooled toxicant biomarker was lower after smokers switched completely to e-cigarettes — with estimated reductions ranging from 61% for NNAL to 92% for NNN — while dual use produced smaller and more variable reductions.

Read article →

Institutions, Funders & Research Networks

Universities, funders, programmes and research communities connected to my academic and research journey.

Contact

Let's collaborate

I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.